September 2025, Volume 2, No. 9
Table of Contents

Letter from the Editors

Free article

At Intuitive Ventures, Managing Partner Murielle Thinard McLane and Senior Partner Terri Burke bring a rare edge to medtech investing: the ability to see around corners. Drawing on decades of experience as operators, startup CEOs, and healthcare executives, they understand how today’s decisions reverberate years into the future. Recent wins, including an impressive $1.5 billion exit, illustrate the fund’s mission, uniquely positioned at the crossroads of bold financial returns and transformational impact on patient care.

Free article

As cardiac ablation procedures surge, the market for diagnostic electrophysiology (EP) catheters is experiencing accelerated growth. Driven by pulsed-field ablation (PFA) adoption, rising arrhythmia incidence, and an expanding product mix, this segment is evolving rapidly. Recent FDA approvals and strategic product launches from top competitors signal a new era of innovation in EP mapping and diagnostics.

Free article

Under the leadership of Co-Founder and CEO Evan Luxon and CBO Randy Preston, Centese is rewriting the playbook for recovery following heart and lung surgery. With more than 15,000 patients treated to date, Centese’s intelligent surgical recovery platform, Thoraguard, is accelerating recovery times, reducing complications, and reshaping the post-operative experience for cardiothoracic patients.

Need fresh inspiration for your medtech company as we enter Q425? We’ve gathered insights from some of our LSI alumni thought leaders to help you stay ahead.

Celebrating recent leadership shifts and other announcements and accolades impacting our global LSI Alumni medtech community.

Select Medtech Industry Financings & Deals: August 2025, by Date Announced

Peripheral vascular guidewires are a foundational technology for transcatheter interventions, enabling safe and precise navigation through the vasculature to treat peripheral vascular disease (PVD). Global demand for these devices is rising steadily, driven by a growing aging population, increased PVD diagnosis, and advancements in access techniques, such as transradial intervention.

Every week, LSI’s Market Intelligence team tracks the signals, strategies, and standout stories shaping the global medtech industry. August brought big moves across M&A, venture, and public markets, with corporates leaning into organ transplant innovation, build-to-buy models gaining ground, mega-rounds stacking up, and IPOs picking up pace. Here’s what defined the pulse of medtech this past month.

This forecast accompanies our Market Dive: Diagnostic Electrophysiology Catheters.

This forecast accompanies our Market Dive: Peripheral Vascular Guidewires.

Backed by 30 years of research and a world-first Nature publication, Heart Biotech is transforming the future of heart valve replacement with a regenerative scaffold that grows a living valve inside the body.

Celebrating the accomplishments of a few of the many bright stars in our LSI presenting company and speaker alumni community.

This month, we’re showcasing technologies and organizations impacting our industry and patient lives.

Trusted By The Companies Pioneering What’s Next

Work with us
Accelerate your business
We’re here to help you make smarter decisions and form stronger
partnerships through curated events, independent market intelligence
products and services, and digital-forward media.